The head of the European Commission, which oversees trade policy in the 27-country European Union, said the bloc was willing to discuss a waiver proposal.
Until now, the EU has been with a group of countries, many of them home to large pharmaceutical companies, including Britain and Switzerland, that have opposed the waiver. Drugmakers, who have produced coronavirus vaccines in record time, oppose the proposal, saying it could disrupt a stretched and fragile supply chain.
Okonjo-Iweala said that only by sitting down together could a solution be found acceptable to all - improving developing countries' access to vaccines and protecting research and innovation vital to production of life-saving vaccines.
According to Reuters, there are concerns, specially by the US administration, that the waiver of COVID-19 vaccine patents to aid poor countries could handover sensitive US biopharmaceutical technology to China and Russia. The waiver of the IP rights means that pporer countries can make their own vaccines. So far the bulk of the vaccines have gone to richer nations who scooped up contracts for them early this year. As a result of this infection rates in richer countries have gone down in contrast infections still rising steadily in 36 countries including India.